retatrutide blindness Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial Reta and The White Eye

Acute treatment of diet-induced obese mice with labelled semaglutide has been shown to allow the drug to access circumventricular organs that lack a substantial blood brain barrier, including the area postrema (AP), median eminence (ME), vascular organ of the lamina terminalis (OV), and subfornical organ (SFO) ( Figure 3 )

PMID: 39212900 Retatrutide acetate purchased from MedChemExpress

Although primarily motivated by the desire to improve weight loss for broad markets, the discovery of highly effective fat-mass selective weight loss regimens is a promising development to help meet the needs of older adults

GLP-1 agonists (semaglutide, dulaglutide, liraglutide) slow gastric emptying as part of their mechanism to control blood glucose and reduce appetite

Can Weight Loss Meds Actually Trigger a Binge